Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

1. Patients with hematological disease survived more than 3 months after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
2. Over 18 years old.
3. Written informed consent or a waiver by the Ethics Committee (EC) at the site.
4. HIV negative, HBV, HCV negative.

1. Previous autologous or allogeneic stem cell transplantation before enrollment.
2. Suffering from mental illness or other conditions and not being able to cooperate with research treatment and monitoring requirements.
3. Patients with other special conditions who were assessed as unqualified by the researchers.

Establishment of Biomarker Panel For Forecasting Chronic Graft-Versus-Host Disease (cGVHD) After Allo-HSCT